Variant report
Variant | esv3389057 |
---|---|
Chromosome Location | chr2:77726644-77730342 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:77726699..77728852-chr2:77733118..77735865,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs536437917 | chr2:77729846-77729847 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs556373481 | chr2:77729897-77729898 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs576252134 | chr2:77729934-77729935 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs545263206 | chr2:77729935-77729936 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs544957419 | chr2:77729938-77729939 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs577520070 | chr2:77729951-77729952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs149234567 | chr2:77729977-77729978 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs550589844 | chr2:77730007-77730008 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs2204916 | chr2:77730014-77730015 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
10 | rs542824803 | chr2:77730051-77730052 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs367757763 | chr2:77730054-77730055 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs201267293 | chr2:77730079-77730080 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs140168011 | chr2:77730080-77730081 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs562642658 | chr2:77730107-77730108 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs143605410 | chr2:77730111-77730112 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs112405824 | chr2:77730128-77730129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs186490482 | chr2:77730189-77730190 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs1344257 | chr2:77730225-77730226 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs62159463 | chr2:77730243-77730244 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs55847661 | chr2:77730247-77730248 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs536374990 | chr2:77730278-77730279 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs368979145 | chr2:77730288-77730289 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs1344256 | chr2:77730308-77730309 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs569875495 | chr2:77730336-77730337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs541124751 | chr2:77730337-77730338 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Lung cancer | 18438408 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Mental retardation | 17124404 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Cancer | 17440070 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Breast cancer | 16272173 | CNVD |
Epilepsy | 22083797 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:77729800-77730200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr2:77729800-77730400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
3 | chr2:77729800-77730400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr2:77729800-77730400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr2:77729800-77730400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
6 | chr2:77729800-77730600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
7 | chr2:77729800-77730800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chr2:77730000-77730400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |